Joseph Dirocco, MD
Colon & Rectal Surgery · Towson, MDNPI 1326201328
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,933 of the $8,134 with a category attached, or 72.9%. It is spread thinly across 21 manufacturers, the largest accounting for just 17.9%. Reporting peaked in 2019 at $3,144 and has fallen 77.3% since, to $713 in 2025.
Across 76 payments — averaging $107.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$1K
- Intuitive Surgical$1K
- Covidien LP$1K
- Johnson & Johnson$796
- Axonics, Inc.$648
- Stryker$496
- plus $2K from 15 others
What the payments were for
- Travel & lodging$1,20115%
- Food & beverage$5,93373%
- Education$1,00012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 9 | $1,452 |
| Intuitive Surgical | 10 | $1,318 |
| Covidien LP | 5 | $1,303 |
| Johnson & Johnson | 10 | $796 |
| Axonics, Inc. | 10 | $648 |
| Stryker | 3 | $496 |
| W. L. Gore & Associates, Inc. | 3 | $406 |
| Integra Lifesciences Corporation | 4 | $363 |
| Medtronic(2 entities) | 4 | $262 |
| THD America, Inc. | 3 | $260 |
| Biom'up SA | 1 | $196 |
| AbbVie | 2 | $158 |
| BD | 1 | $150 |
| Kerecis Limited | 2 | $107 |
| Pacira Pharmaceuticals Incorporated | 1 | $95 |
| Braintree Laboratories, Inc. | 3 | $47 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Ardelyx, Inc. | 1 | $19 |
| TELA Bio, Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,000
- INTEGRA$885
- Phasix Mesh$789
- Enseal X1$413
- Axonics$399
- PHASIX$328
- 1788$323
- ARISTA AH FLEXITIP$312
- INTEGRA DERMAL REGENERATION TEMPLATE$295
- PRIMATRIX$295
- STRATAFIX$265
- HEMOBLAST$196
- SPY-PHI SYSTEM$173
- GORE SEAMGUARD Bioabsorbable Staple Line Reinforce$150
- Echelon Circular$144
- SYNECOR Biomaterial$143
- STRATTICE$133
- PROGEL$118
- INTERSTIM$116
- GORE SYNECOR Preperitoneal Biomaterial$113
How this compares
$8,134 in reported general payments places this provider in the 75th percentile of 29 colon & rectal surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MotegrityPrucalopride Succinate | 12 | $7,175 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 66 | $1,894 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 11 | $1,764 |
| Tramadol Hcl | 32 | $459 |
| ErythromycinErythromycin Base | 17 | $261 |
| Hydrocortisone | 28 | $254 |
| Lactulose | 18 | $212 |
| Ondansetron OdtOndansetron | 25 | $202 |
| Procto-Med HcHydrocortisone | 11 | $176 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $144 |
| Metronidazole | 25 | $65 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braintree Laboratories, Inc.Sutab | $47 | $1,76411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 29 colon & rectal surgery providers in Maryland.
Other colon & rectal surgery in Towson
- Ivane ChuaTowson$10K
- Valerie Cabrera LeonTowson$10K
- Irina BernescuBaltimore$93K
- Bashar SafarBaltimore$26K
- Joshua WolfBaltimore$24K
- Philip FerrisBaltimore$11K
- James ZaluckiEllicott City$5K
- James DuncanBethesda$5K
- Chady AtallahBaltimore$4K
- Benjamin QuarteyBethesda$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.